Desarrollo de un protocolo para la derivación de los pacientes con células atípicas en el sedimento urinario: experiencia del hospital de Móstoles

Messing E. Tumores uroteliales del tracto urinario. En: Wein A, Vaughan D, Retik A, Walsh PC, editores. Campbell. Urología. 8.a ed. Filadelfia: Panamericana; 2005. p. 2983–90. Dalet, 2000 Hoflmayr, 1981, Estandarizacion del sedimento urinario; progreso en el urianalisis, Urologe, 21, 295 Gaston, 2004, Value of urinary cytology in the diagnosis and management of urinary tract malignancies, Urology, 63, 1009, 10.1016/j.urology.2003.12.004 Shenoy, 1985, Reliability of urinary cytodiagnosis in urothelial neoplasma, Cancer, 56, 2041, 10.1002/1097-0142(19851015)56:8<2041::AID-CNCR2820560826>3.0.CO;2-D Grzetic, 2004, Value of urinary sediment cy tology in evaluation of acute tubular necrosis alter kidney transplantation, Acta Med Croatica, 58, 19 Chauvin, 1957, Possibilities of urinary cytology in the diagnosis of renal and vesical cancer; 84 cases, Mars Chir, 9, 711 Murphy, 1990, Current status of urinary cytology in the evaluation of bladder neoplasms, Hum Pathol, 21, 886, 10.1016/0046-8177(90)90171-Z Netto Júnior, 1981, The value of urinary cytology in vesical carcinoma, AMB Rev Assoc Med Bras, 27, 200 Albert, 1977, Urine cytology estudies in bladder tumors, Z Urol Nephrol, 70, 231 Fernández, 2002, Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma, Arch Esp Urol, 55, 41 Koening, 1999, Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence inducen by 5-aminolaevulinic acid, BJU Int, 83, 129, 10.1046/j.1464-410x.1999.00917.x Schneider, 2000, Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer, Cancer Res, 60, 4617 Olsson, 2001, ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma, Scand J Urol Nephrol, 35, 280, 10.1080/003655901750425846 Zaak, 2001, Quantification of 5- aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection, J Urol, 166, 1665, 10.1016/S0022-5347(05)65649-2 Babjuk, 2002, Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder, Eur Urol, 41, 34, 10.1016/S0302-2838(01)00015-X Zaak, 2002, Ultraviolet-excited (308nm) autofluorescence for bladder cancer detection, Urology, 60, 1029, 10.1016/S0090-4295(02)01999-4 Mansoor, 2003, Analysis of urine cytology at a community hospital, J Ayub Med Coll Abbottabad, 15, 20 Eissa, 2003, Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer, Eur Urol, 44, 687, 10.1016/S0302-2838(03)00417-2 Jaganath, 2004, Diagnostic classification of urothelial cells in urine cytology specimens using exclusively spectral information, Cancer, 102, 186, 10.1002/cncr.20302 Davies, 2005, Efficacy of BTA stat, cytology, and survivin in bladder cancer surveillance over 5 years in patients with spinal cord injury, Urology, 66, 908, 10.1016/j.urology.2005.05.022 Franpton, 2006, Hexyl aminolevulinate: in the detection of bladder cancer, Drugs, 66, 571, 10.2165/00003495-200666040-00010 Helmy, 2007, The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in inmmune escape mechanism in bladder cancer, Med Gen Med, 9, 34